Scott Webster

Scott Webster has held various positions in the field of drug discovery and technology over the past two decades. In 2020, they began working as both the Chief Technology Officer and Chief Scientific Officer at Kynos Therapeutics Ltd. Prior to this, they were a Professor of Medicines Discovery at The University of Edinburgh from 2017-2020. From 2003-2017, they held various roles at the University of Edinburgh, including Reader in Drug Discovery, Senior Lecturer & Director of Drug Discovery Core, and Drug Discovery Manager. Before that, they worked as the Head of Enzymology at PanTherix Ltd from 1999-2003.

Scott Webster attended The University of Edinburgh, where they earned a BSc and PhD in Chemistry.